Oxidative Stress Levels in Myelodysplastic Syndrome Patients: Their Relationship to Serum Ferritin and Haemoglobin Values

Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndrome

(2011) Hussam Ghoti et al.   BRITISH JOURNAL OF HAEMATOLOGY

Comparison of Clinically Used and Experimental Iron Chelators for Protection against Oxidative Stress-Induced Cellular Injury

(2010) Petra Bendova et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Iron chelation therapy associated with improvement of hematopoiesis in transfusion-dependent patients

(2010) Esther Natalie Oliva et al.   TRANSFUSION

Depletion of l-ascorbic acid alternating with its supplementation in the treatment of patients with acute myeloid leukemia or myelodysplastic syndromes

(2009) Chan H. Park et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Oxidative status in iron-deficiency anemia

(2009) Jong-Ha Yoo et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Regulation of TNF-induced oxygen radical production in human neutrophils: role of δ-PKC

(2009) Laurie E. Kilpatrick et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Urinary hepcidin excretion in patients with myelodysplastic syndrome and myelofibrosis

(2008) Asher Winder et al.   BRITISH JOURNAL OF HAEMATOLOGY

Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia

(2008) Alev Akyol Erikci et al.   Hematology

Body iron metabolism and pathophysiology of iron overload

(2008) Yutaka Kohgo et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

NF-kappaB: a potential target for cancer chemoprevention and therapy

(2007) Fazlul et al.   Frontiers in Bioscience-Landmark